Flatiron Health
Integrations
- Epic
- Cerner
- HL7 FHIR
- Varian
- Foundation Medicine
Pricing Details
- Pricing is undisclosed and based on customized partnership agreements including data volume and research modules.
- Typically involves multi-year commitments.
Features
- Unified Oncology Data Layer
- NLP-Assisted Human-in-the-loop Abstraction
- Clinical Trial Matching (OncoTrials)
- Clinical Pipe EDC Integration
- OMOP CDM Standardization
- HIPAA-Compliant De-identification Engine
Description
Flatiron Health Architectural Assessment
Flatiron Health’s architecture is centered on a Unified Oncology Data Layer that functions as a centralized aggregator for clinical data. Unlike federated models, Flatiron utilizes a Cloud-Native Ingestion Pipeline to pull data from distributed oncology practices into a multi-tenant environment for centralized processing and normalization 🧠. This architecture enables the transformation of raw clinical inputs into the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) 📑.
Operational Scenarios
- Clinical Abstraction: Input: Unstructured Pathology Reports and Clinician Notes -> Process: NLP-assisted Human-in-the-loop Abstraction -> Output: Structured TNM Staging and Biomarker Variables 📑.
- RWE Generation: Input: Longitudinal EHR Records -> Process: De-identification, Normalization, and Mapping -> Output: Research-Grade Dataset for Regulatory Submission 📑.
- Clinical Trial Matching: Input: Real-time Patient Records -> Process: Rule-based eligibility screening against NCCN guidelines -> Output: Pre-screened Patient Cohorts for OncoTrials 📑.
⠠⠉⠗⠑⠁⠞⠑⠙⠀⠃⠽⠀⠠⠁⠊⠞⠕⠉⠕⠗⠑⠲⠉⠕⠍
Security & Compliance Architecture
The platform implements a multi-layered security framework focused on the protection of Protected Health Information (PHI). Data is processed through a proprietary de-identification engine to ensure compliance with the HIPAA Expert Determination method before being utilized for research 📑.
- Access Control: Employs role-based access controls (RBAC) and audit logging for all data mediation activities 🧠.
- Data Sovereignty: Utilizes isolated logical abstraction layers to maintain data integrity for multi-institutional research collaborations 📑.
Interoperability & Integration Layer
Flatiron utilizes a Healthcare Interoperability Adapter pattern to interface with external EHR systems. This facilitates bidirectional data flow, particularly through the 'Clinical Pipe' module which automates the transfer of data from EMRs to electronic data capture (EDC) systems 📑.
- Protocol Support: Connectivity via HL7 FHIR and RESTful APIs for real-time data ingestion 📑.
- Oncology Standard Mapping: Native support for AJCC staging and RECIST criteria in the data normalization phase 📑.
Evaluation Guidance
Technical evaluators should verify the specific latency and throughput of the 'Clinical Pipe' during high-volume data transfers. Organizations must request documentation regarding the specific de-identification algorithms used for unstructured text to ensure alignment with institutional risk tolerance 🌑. Validate the manual verification ratios in the abstraction process to determine the effective human-in-the-loop overhead 🌑.
Release History
Year-end update: Release of the Agentic Trial Orchestrator. AI agents autonomously identify and pre-screen patients for trials across 280+ cancer clinics.
Launch of a unified patient-centric portal. Combines clinical RWD with real-time Patient-Reported Outcomes (ePRO) for holistic monitoring.
Integrated LLMs for automated data abstraction. AI now extracts complex clinical variables from unstructured doctor notes with human-level accuracy.
General availability of Flatiron Assist. A clinical decision support tool integrated into the EMR to ensure adherence to NCCN Guidelines.
Launch of Clinical Pipe. Automated the transfer of data from EMRs directly into electronic data capture (EDC) systems for clinical trials.
Flatiron Health acquired by Roche for $1.9B. Shifted focus towards large-scale Real-World Evidence (RWE) for drug development and regulatory submissions.
Initial launch of the OncoCloud platform. Integrated OncoEMR with advanced data analytics to support community oncology practices.
Tool Pros and Cons
Pros
- Unique oncology data
- Accelerated drug development
- Clinical trial support
- Data-driven insights
- Cancer research improvement
Cons
- Data compliance complexity
- Potentially high cost
- Data standardization needed